Tumors of the esophagogastric junction

Slides:

Advertisements

Similar presentations

Fig. 1: Regional abdominal lymph node dissection during 2-field LND. Fig. 2: full mobilisation of spleen and pancreatic tail to allow complete LND of.

Advertisements

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Stephen R. Broderick, MD, MPHS

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the.

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Survival of patients with distal esophageal and gastric cardia tumors: A population- based analysis of gastroesophageal junction carcinomas Bryan A. Whitson,

Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy John J. Nigro, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen,

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Surgical treatment of thoracoabdominal aortic aneurysms by simple crossclamping: Risk factors and late results Marc A.A.M. Schepens, MD, Jo J.A.M. Defauw,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Factors predictive of prognosis after esophagectomy for squamous cell cancer Houhuai Li, MD, PhD, Qingzhen Zhang, Lin Xu, MD, Yijiang Chen, Yongxiang.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Victor van Berkel, MD, PhD

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD

Esophageal Ultrasound-Controlled Fine Needle Aspiration for Staging of Mediastinal Lymph Nodes in Patients with Resectable Lung Cancer: Do We Always See.

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Lorenzo Spaggiari, MD, PhD, Ugo Pastorino, MD

Editorial: The core of leadership

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Proposed Revision Of The Staging Classification For Esophageal Cancer

The Prognostic Value of the Number of Negative Lymph Nodes in Esophageal Cancer Patients After Transthoracic Resection Po-Kuei Hsu, MD, Chien-Sheng Huang,

The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer P. Flamen, MD, A. Lerut, MD, PhD, E. Van Cutsem,

Subclavian artery involvement by apical chest tumors: A specific indication for the transmanubrial approach Lorenzo Spaggiari, MD, PhD, Ugo Pastorino,

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

Thymic neuroendocrine carcinoma (carcinoid): A clinicopathologic study of fourteen cases Vincent Thomas de Montpréville, MDa, Paolo Macchiarini, MDb,

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Importance of Lymph Node Dissection in Thymic Carcinoma

Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy

Stephen R. Broderick, MD, MPHS

Nael Martini, MDa, Muhammad B. Zaman, MDb, Manjit S

Intrathoracic Lymph Node Metastases From Extrathoracic Carcinoma: The Place for Surgery Marc Riquet, MD, Pascal Berna, MD, Emmanuel Brian, MD, Alain.

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology.

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD

Refining the Nodal Staging for Esophageal Squamous Cell Carcinoma Based on Lymph Node Stations Jun Peng, MD, Wen-Ping Wang, MD, Ting Dong, MD, Jie Cai,

It’s All in the “Swerve of the Curve”

Patient recovery after intermittent disc escape and spontaneous recession of a mechanical heart valve Francis Robicsek, MD, PhD, Joseph W. Cook, MD

Increase in size of the pulmonary autograft after the ross operation in children: Growth or dilation? Laszlo Solymar, MD, PhD, Göran Südow, MD, Daniel.

Manuel J. Antunes, MD, PhD, DSc

Lymph Node Metastasis In Small Peripheral Adenocarcinoma Of The Lung

Survival after Trimodality Treatment for Superior Sulcus and Central T4 Non-small Cell Lung Cancer Paul De Leyn, MD, PhD, Johan Vansteenkiste, MD, PhD,

Carcinoma of the esophagus: Prognostic significance of histologic type

Prognosis and “granularity”: Building on staging foundations?

The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma Tara A. Waterman, BA, Jeffrey A. Hagen,

Thomas W. Rice, MD The Journal of Thoracic and Cardiovascular Surgery

O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M

Superior sulcus lung tumors: Impact of local control on survival

Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Neal S Goldstein, MD The Annals of Thoracic Surgery

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Prognostic factors and long-term results after thymoma resection: A series of 307 patients Jean-François Regnard, MDa, Pierre Magdeleinat, MDa, Christian.

Who should decide margin length in pulmonary excision of lung cancer?

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Presentation transcript:

Tumors of the esophagogastric junction W.H. Steup, MD, PhD (by invitation), P. De Leyn, MD, PhD (by invitation), G. Deneffe, MD (by invitation), D. Van Raemdonck, MD (by invitation), W. Coosemans, MD (by invitation), T. Lerut, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 111, Issue 1, Pages 85-95 (January 1996) DOI: 10.1016/S0022-5223(96)70404-X Copyright © 1996 Mosby, Inc. Terms and Conditions

Fig. 1 Overall survival in years after resection for tumors of the esophagogastric junction. The Journal of Thoracic and Cardiovascular Surgery 1996 111, 85-95DOI: (10.1016/S0022-5223(96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

Fig. 2 Survival curves according to pTNM staging after resection for tumors of the esophagogastric junction. The Journal of Thoracic and Cardiovascular Surgery 1996 111, 85-95DOI: (10.1016/S0022-5223(96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

Fig. 3 Survival curves according to absence or presence of lymph node involvement after resection for tumors of the esophagogastric junction. The Journal of Thoracic and Cardiovascular Surgery 1996 111, 85-95DOI: (10.1016/S0022-5223(96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

Fig. 4 Survival curves according to lymph node involvement of abdominal and abdominal plus thoracic lymph nodes after resection for tumors of the esophagogastric junction. LN, Lymph node; +, positive (diseased); -, negative (normal). The Journal of Thoracic and Cardiovascular Surgery 1996 111, 85-95DOI: (10.1016/S0022-5223(96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

Fig. 5 Survival curves according to pTNM staging after resection for tumors of the esophagogastric junction that were classified as esophageal carcinomas. The Journal of Thoracic and Cardiovascular Surgery 1996 111, 85-95DOI: (10.1016/S0022-5223(96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions

Fig. 6 Survival curves after regrouping of patients originally classified as having IIIb or M+Ly intrathoracic disease. Patients with T4 tumors are excluded. Staging is classified as gastric carcinoma. The Journal of Thoracic and Cardiovascular Surgery 1996 111, 85-95DOI: (10.1016/S0022-5223(96)70404-X) Copyright © 1996 Mosby, Inc. Terms and Conditions